Listar Artículos de revista DCS - OZS Aldizkari artikuluak por autor "Guerrero Setas, David"
Mostrando ítems 1-7 de 7
-
Absence of nuclear p16 is a diagnostic and independent prognostic biomarker in squamous cell carcinoma of the cervix
Mendaza Lainez, Saioa
; Fernández Irigoyen, Joaquín 
; Santamaría, Enrique; Zudaire, Tamara; Guarch, Rosa; Guerrero Setas, David (MDPI, 2020)
Artículo / Artikulua 
The tumor-suppressor protein p16 is paradoxically overexpressed in cervical cancer (CC). Despite its potential as a biomarker, its clinical value and the reasons for its failure in tumor suppression remain unclear. Our ... -
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
Martín Sánchez, Esperanza; Mendaza Lainez, Saioa; Ulazia Garmendia, Ane; Monreal Santesteban, Iñaki; Córdoba Iturriagagoitia, Alicia; Vicente García, Francisco; Blanco Luquin, Idoia; Cruz, Susana de la; Aramendia, Ana; Guerrero Setas, David (BioMed Central, 2017)
Artículo / Artikulua
Background: Cadherin-like protein 22 (CDH22) is a transmembrane glycoprotein involved in cell-cell adhesion and metastasis. Its role in cancer is controversial because it has been described as being upregulated in ... -
A DNA methylation-based gene signature can predict triple-negative breast cancer diagnosis
Mendaza Lainez, Saioa; Guerrero Setas, David; Monreal Santesteban, Iñaki; Ulazia Garmendia, Ane; Córdoba Iturriagagoitia, Alicia; Cruz, Susana de la; Martín Sánchez, Esperanza (MDPI, 2021)
Artículo / Artikulua
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer (BC) subtype and lacks targeted treatment. It is diagnosed by the absence of immunohistochemical expression of several biomarkers, but this method ... -
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
Arechederra, María; Rullán, María ; Amat Villegas, Irene ; Oyón, Daniel; Zabalza, Lucía; Elizalde, María; Latasa, Maria Ujue; Mercado Gutiérrez, María R.; Ruiz-Clavijo, Daniel; Saldaña, Cristina; Fernández-Urién Sainz, Ignacio; Carrascosa, Juan; Jusué, Vanesa; Guerrero Setas, David; Zazpe, Cruz; González Borja, Iranzu; Sangro, Bruno; Herranz, José M.; Purroy, Ana; Gil, Isabel; Nelson, Leonard J.; Vila, Juan J.; Krawczyk, Marcin; Zieniewicz, Krzysztof; Patkowski, Waldemar; Milkiewicz, Piotr; Cubero, Francisco Javier; Alkorta Aranburu, Gorka; Fernández-Barrena, Maite G.; Urman, Jesús M.; Berasain, Carmen; Ávila, Matías A. (BMJ Publishing Group, 2021)
Artículo / Artikulua
Objective: despite significant progresses in imaging and pathological evaluation, early differentiation between benign and malignant biliary strictures remains challenging. Endoscopic retrograde cholangiopancreatography ... -
A novel prognostic biomarker panel for early‐stage colon carcinoma
Azcue Sanromán, Pablo; Guerrero Setas, David; Encío Martínez, Ignacio ; Ibáñez Beroiz, B. ; Mercado Gutiérrez, María R.; Vera García, Ruth; Gómez Dorronsoro, María Luisa (MDPI, 2021)
Artículo / Artikulua
Molecular characterization of colorectal cancer has helped us understand better the biology of the disease. However, previous efforts have yet to provide significant clinical value in order to be integrated into clinical ... -
PD-L1 as a prognostic factor in early-stage colon carcinoma within the immunohistochemical molecular subtype classification
Azcue Sanromán, Pablo; Encío Martínez, Ignacio ; Guerrero Setas, David; Suárez Alecha, Javier; Galbete Jiménez, Arkaitz ; Mercado Gutiérrez, María R.; Vera García, Ruth; Gómez Dorronsoro, María Luisa (MDPI, 2021)
Artículo / Artikulua
Colorectal cancer (CRC) is a very heterogeneous disease. Efforts to characterize and search for biomarkers for these patients are currently ongoing in the hope of establishing a more targeted therapeutic approach. The role ... -
ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer
(BMC, 2023) Artículo / Artikulua
Background: Colon cancer (CC) is a heterogeneous disease that is categorized into four Consensus Molecular Subtypes (CMS) according to gene expression. Patients with loco-regional CC (stages II/III) lack prognostic factors, ...
